Balance Sheet Components (Tables)

9 Months Ended

Sep. 30, 2023

Organization and Operations

Schedule of Property and Equipment, Net

Property and equipment, net consisted of the following:

	September 30,		December 31,
(in thousands)	2023		2022
Machinery and equipment	$	13,141	$	12,944
Computer equipment and software		3,232		3,183
Furniture and fixtures		1,258		1,258
Leasehold improvements		6,234		6,198
Finance lease right of use assets		2,663		4,632
Construction in progress		407		696
Total property and equipment		26,935		28,911
Accumulated depreciation and amortization		(20,866)		(20,157)
Property and equipment, net	$	6,069	$	8,754

Schedule of Goodwill and Intangible Assets, Net

	September 30,		December 31,
(in thousands)	2023		2022
Goodwill	$	943	$	943
Indefinite-lived assets - IPR&D		28,859		2,620
Finite-lived assets, net		16,722		2,368
Total Goodwill and intangible assets, net	$	46,524	$	5,931

Schedule of Accrued Liabilities

Accrued and other current liabilities consisted of the following:

	September 30,		December 31,
(in thousands)	2023		2022
Accrued commercial and research and development manufacturing	$	17,057	$	21,774
Accrued co-development costs payable to Junshi Biosciences		1,293		8,356
Accrued royalties		30,557		5,015
Accrued other		9,698		10,634
Lease liabilities, current		4,469		4,318
Contingent consideration, current		4,040		—
Total Accrued and other current liabilities	$	67,114	$	50,097

Schedule of Other Liabilities, Non-current

	September 30,		December 31,
(in thousands)	2023		2022
Contingent consideration, non-current	$	1,352	$	102
Deferred tax liability		1,102		—
Other		1,059		3,365
Total Other liabilities, non-current	$	3,513	$	3,467